tiprankstipranks
Helix BioPharma (TSE:HBP)
TSX:HBP

Helix BioPharma (HBP) Financial Statements

23 Followers

Helix BioPharma Financial Overview

Helix BioPharma's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Helix BioPharma is scheduled to report earnings on June 11, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 23Jul 23Apr 23Jan 23Oct 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.25MC$ -2.16MC$ -1.33MC$ -1.18M-
EBITDAC$ -1.25MC$ -2.16MC$ -1.33MC$ -1.18M-
Net Income Common StockholdersC$ -1.25MC$ -2.16MC$ -1.34MC$ -1.19M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.64MC$ 808.00KC$ 1.33MC$ 2.82M-
Total AssetsC$ 1.90MC$ 1.03MC$ 1.59MC$ 3.20M-
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -1.64MC$ -808.00KC$ -1.33MC$ -2.82MC$ 0.00
Total LiabilitiesC$ 1.27MC$ 1.87MC$ 674.00KC$ 973.00K-
Stockholders EquityC$ 622.00KC$ -844.00KC$ 913.00KC$ 2.23M-
Cash Flow-
Free Cash FlowC$ -1.84MC$ -1.54MC$ -4.00M--
Operating Cash FlowC$ -1.83MC$ -1.54MC$ -3.99M--
Investing Cash FlowC$ -12.00KC$ 4.00KC$ -9.00K--
Financing Cash FlowC$ 2.69MC$ 997.00KC$ 2.09M--
Currency in CAD

Helix BioPharma Earnings and Revenue History

Helix BioPharma Debt to Assets

Helix BioPharma Cash Flow

Helix BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis